MOH vs. HUM, CNC, STE, ALNY, ALGN, BNTX, GMAB, WAT, COO, and BAX
Should you be buying Molina Healthcare stock or one of its competitors? The main competitors of Molina Healthcare include Humana (HUM), Centene (CNC), STERIS (STE), Alnylam Pharmaceuticals (ALNY), Align Technology (ALGN), BioNTech (BNTX), Genmab A/S (GMAB), Waters (WAT), Cooper Companies (COO), and Baxter International (BAX). These companies are all part of the "medical" sector.
Molina Healthcare (NYSE:MOH) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.
Molina Healthcare has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500.
Humana received 357 more outperform votes than Molina Healthcare when rated by MarketBeat users. Likewise, 64.15% of users gave Humana an outperform vote while only 56.91% of users gave Molina Healthcare an outperform vote.
Molina Healthcare presently has a consensus price target of $404.90, indicating a potential upside of 14.18%. Humana has a consensus price target of $424.50, indicating a potential upside of 26.49%. Given Humana's stronger consensus rating and higher possible upside, analysts plainly believe Humana is more favorable than Molina Healthcare.
Humana has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.
Molina Healthcare has a net margin of 2.99% compared to Humana's net margin of 1.82%. Molina Healthcare's return on equity of 29.86% beat Humana's return on equity.
In the previous week, Humana had 10 more articles in the media than Molina Healthcare. MarketBeat recorded 18 mentions for Humana and 8 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.17 beat Humana's score of 0.30 indicating that Molina Healthcare is being referred to more favorably in the media.
98.5% of Molina Healthcare shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 1.1% of Molina Healthcare shares are owned by insiders. Comparatively, 0.3% of Humana shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
Molina Healthcare and Humana tied by winning 9 of the 18 factors compared between the two stocks.
Get Molina Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for MOH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MOH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Molina Healthcare Competitors List
Related Companies and Tools
